These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38789058)

  • 1. MRI-derived brain iron, grey matter volume, and risk of dementia and Parkinson's disease: Observational and genetic analysis in the UK Biobank cohort.
    Casanova F; Tian Q; Williamson DS; Qian Y; Zweibaum D; Ding J; Atkins JL; Melzer D; Ferrucci L; Pilling LC
    Neurobiol Dis; 2024 Jul; 197():106539. PubMed ID: 38789058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia.
    Li DTH; Hui ES; Chan Q; Yao N; Chua SE; McAlonan GM; Pang SYY; Ho SL; Mak HKF
    Neuroimage Clin; 2018; 20():365-373. PubMed ID: 30128274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of QSM over R2* in assessment of parkinson's disease - A systematic review.
    Saikiran P;
    Neurol India; 2020; 68(2):278-281. PubMed ID: 32415005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Susceptibility Mapping in Parkinson's Disease.
    Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
    PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron and risk of dementia: Mendelian randomisation analysis in UK Biobank.
    Casanova F; Tian Q; Atkins JL; Wood AR; Williamson D; Qian Y; Zweibaum D; Ding J; Melzer D; Ferrucci L; Pilling LC
    J Med Genet; 2024 Apr; 61(5):435-442. PubMed ID: 38191510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
    Meng H; Zhang D; Sun Q
    Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between moderate alcohol consumption, brain iron, and cognition in UK Biobank participants: Observational and mendelian randomization analyses.
    Topiwala A; Wang C; Ebmeier KP; Burgess S; Bell S; Levey DF; Zhou H; McCracken C; Roca-Fernández A; Petersen SE; Raman B; Husain M; Gelernter J; Miller KL; Smith SM; Nichols TE
    PLoS Med; 2022 Jul; 19(7):e1004039. PubMed ID: 35834561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
    Yan S; Lu J; Li Y; Cho J; Zhang S; Zhu W; Wang Y
    Eur Radiol; 2024 May; 34(5):3074-3083. PubMed ID: 37853173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.
    Kim M; Yoo S; Kim D; Cho JW; Kim JS; Ahn JH; Mun JK; Choi I; Lee SK; Youn J
    Neurol Sci; 2021 Dec; 42(12):5297-5304. PubMed ID: 33860863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain iron assessment in patients with First-episode schizophrenia using quantitative susceptibility mapping.
    Xu M; Guo Y; Cheng J; Xue K; Yang M; Song X; Feng Y; Cheng J
    Neuroimage Clin; 2021; 31():102736. PubMed ID: 34186296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcortical grey matter changes in untreated, early stage Parkinson's disease without dementia.
    Lee HM; Kwon KY; Kim MJ; Jang JW; Suh SI; Koh SB; Kim JH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):622-6. PubMed ID: 24703894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain iron deposition is linked with cognitive severity in Parkinson's disease.
    Thomas GEC; Leyland LA; Schrag AE; Lees AJ; Acosta-Cabronero J; Weil RS
    J Neurol Neurosurg Psychiatry; 2020 Apr; 91(4):418-425. PubMed ID: 32079673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.
    Barbosa JH; Santos AC; Tumas V; Liu M; Zheng W; Haacke EM; Salmon CE
    Magn Reson Imaging; 2015 Jun; 33(5):559-65. PubMed ID: 25721997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in iron load in specific brain areas lead to neurodegenerative diseases of the central nervous system.
    Wang X; Zhu Z; Sun J; Jia L; Cai L; Chen Q; Yang W; Wang Y; Zhang Y; Guo S; Liu W; Yang Z; Zhao P; Wang Z; Lv H
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110903. PubMed ID: 38036035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
    Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
    Front Immunol; 2022; 13():956005. PubMed ID: 36159838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional Structural Hippocampal Differences Between Dementia with Lewy Bodies and Parkinson's Disease.
    de Schipper LJ; Hafkemeijer A; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
    J Parkinsons Dis; 2019; 9(4):775-783. PubMed ID: 31524178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron and neuromelanin imaging in basal ganglia circuitry in Parkinson's disease with freezing of gait.
    Zhang Y; Zhang C; Wang X; Liu Y; Jin Z; Haacke EM; He N; Li D; Yan F
    Magn Reson Imaging; 2024 Sep; 111():229-236. PubMed ID: 38777243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.